Location: West Conshohocken, PA
CIK: 0001802528 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.513B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORKA | ORUKA THERAPEUTICS INC | 3,705,262 | $353M | 23.3% | — | — | COM | 687604108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,537,191 | $247M | 16.3% | — | — | COM | 252828108 |
| GLTO | DAMORA THERAPEUTICS INC | 8,713,000 | $227M | 15.0% | — | — | COM NEW | 36322Q206 |
| COGT | COGENT BIOSCIENCES INC | 5,503,418 | $213M | 14.1% | — | — | COM | 19240Q201 |
| JBIO | JADE BIOSCIENCES INC | 4,553,494 | $101M | 6.7% | — | — | COM NEW | 008064206 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,855,644 | $94.17M | 6.2% | — | — | COM | 29337E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 5,090,928 | $93.52M | 6.2% | — | — | COM | 92790C104 |
| ZBIO | ZENAS BIOPHARMA INC | 2,359,025 | $59.87M | 4.0% | — | — | COM | 98937L105 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,747,866 | $49.46M | 3.3% | — | — | COM | G2545C104 |
| APGE | APOGEE THERAPEUTICS INC | 298,647 | $39.64M | 2.6% | — | — | COM | 03770N101 |
| SNSE | FAETH THERAPEUTICS INC | 722,020 | $18.05M | 1.2% | — | — | COM NEW | 81728A207 |
| IKT | INHIBIKASE THERAPEUTICS INC | 8,625,000 | $17.51M | 1.2% | — | — | COM NEW | 45719W205 |